Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
The Z-scores for all participants and T-scores from postmenopausal women and men ≥ 50-year-old were analyzed and correlated with various measures including disease duration, BMI, renal function (measured by eGFR), plasma GL3, Lyso-GL3, calcium, vitamin D, and alkaline phosphatase levels.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Subsequently, to determine the frequency of osteoporosis and osteopenia, T−scores were used to define bone density status in postmenopausal women and men aged 50 years and older: a T-score of −1 to −2.5 indicates osteopenia.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Assessing osteopenia and osteoporosis with dual-energy x-ray absorptiometry studies in Fabry disease
Study design awaiting verification · Orphanet Journal of Rare Diseases · 2025
Original publication title
Assessing osteopenia and osteoporosis with dual-energy x-ray absorptiometry studies in Fabry disease
© The Author(s) 2025
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Fabry disease (FD) is a rare multi-systemic lysosomal storage disease that affects the heart and kidneys most significantly. An underappreciated manifestation of FD is reduced bone mineral density. Currently, there are no specific guidelines for routine bone density assessments, and treatment of osteoporosis and osteopenia in FD.
Source: BackgroundAbstract: What methods does the paper describe?
To ascertain the frequency of low bone mineral density in FD we studied dual-energy x-ray absorptiometry (DXA) scans obtained as part of routine care from a cohort of 25 individuals followed at the University of California: Irvine Medical Center for the period 2008 to 2023. The most recent BMD results for the lumbar spine and femoral neck were collected from 12 males and 13 females to examine the prevalence of low bone mineral density. The lowest Z: and/or T-scores of either lumbar spine or femoral neck were selected for analysis.
Demographic factors, disease and ERT status, and other laboratory values were collected concurrently (within ± 9 months) with DXA scan results and were analyzed with Z: and T-scores to assess for correlations. In our cohort the mean age was 51 years (median 56 years, range 18 to 77 years). The Z-scores for all participants and T-scores from postmenopausal women and men ≥ 50-year-old were analyzed and correlated with various measures including disease duration, BMI, renal function (measured by eGFR), plasma GL3, Lyso-GL3, calcium, vitamin D, and alkaline phosphatase levels.
These parameters were concurrent with DXA scan results.
Source: Materials and methodsAbstract: Results
The average Z-score for all the participants was −1.2 ± 1.3 (range −4.6 to 1.6). Twenty-four percent of all participants (n = 6) had significantly low Z-scores ≤ −2.0. To identify the frequency of subjects with osteopenia, defined as T-score between −1.0 and −2.5 and osteoporosis defined as T-score < −2.5, T-scores were analyzed in postmenopausal women (n = 8) and men 50 years and older (n = 7). Of these 15 individuals, average T-score was −2.2 ± 1.3 (range −5.4 to 0.3), and 86.7% (n = 13) had abnormal results (osteopenia and osteoporosis), 53.3% (n = 8) had osteoporosis and 33.3% (n = 5) had osteoporosis.
We found a significant difference in Z-scores between male (−1.98 ± 1.33) and female patients (−.45 ± 0.82) t (23) = 3.487 (p = < 0.001). We did not find any differences in z-scores between different ethnic backgrounds. There was a strong negative correlation between Z-scores and Lyso-GL3 levels [r (15) = −.72, p = .001] and a moderate positive correlation between Z-scores and body mass index (BMI) [r (23) = .43, p = .033]. No correlation was found between Z-scores and calcium levels.
There is a strong negative correlation between T-scores and Lyso-GL3 levels [r (8) =: .86, p = .001] and a negative correlation between T-scores and participants’ ages at the time of DXA [r (13) = −.57, p = 0.028]. There is a positive correlation between T: scores and calcium levels [r (12) = .58, p = 0.030]. No significant correlation was observed between T-scores and BMI. There was no correlation between Z or T: scores and disease duration, duration of ERT use, renal function (measured by eGFR), GL3, creatinine, alkaline phosphatase levels, or their use of vitamin D or concomitant antiepileptic medications.
Source: ResultsAbstract: Conclusion
The findings of this cohort highlight the high prevalence of low bone mineral density in FD and correlations of low Z and T: scores with elevated levels of Lyso-GL3, and low calcium levels. We did not find correlations with renal function, and vitamin D levels. We discuss etiology, prevention, and treatment strategies for osteopenia/osteoporosis in Fabry disease.
Source: ConclusionAuthors’ abstract
Background
Fabry disease (FD) is a rare multi-systemic lysosomal storage disease that affects the heart and kidneys most significantly. An underappreciated manifestation of FD is reduced bone mineral density. Currently, there are no specific guidelines for routine bone density assessments, and treatment of osteoporosis and osteopenia in FD.
Materials and methods
To ascertain the frequency of low bone mineral density in FD we studied dual-energy x-ray absorptiometry (DXA) scans obtained as part of routine care from a cohort of 25 individuals followed at the University of California: Irvine Medical Center for the period 2008 to 2023. The most recent BMD results for the lumbar spine and femoral neck were collected from 12 males and 13 females to examine the prevalence of low bone mineral density. The lowest Z: and/or T-scores of either lumbar spine or femoral neck were selected for analysis.
Demographic factors, disease and ERT status, and other laboratory values were collected concurrently (within ± 9 months) with DXA scan results and were analyzed with Z: and T-scores to assess for correlations. In our cohort the mean age was 51 years (median 56 years, range 18 to 77 years). The Z-scores for all participants and T-scores from postmenopausal women and men ≥ 50-year-old were analyzed and correlated with various measures including disease duration, BMI, renal function (measured by eGFR), plasma GL3, Lyso-GL3, calcium, vitamin D, and alkaline phosphatase levels.
These parameters were concurrent with DXA scan results.
Results
The average Z-score for all the participants was −1.2 ± 1.3 (range −4.6 to 1.6). Twenty-four percent of all participants (n = 6) had significantly low Z-scores ≤ −2.0. To identify the frequency of subjects with osteopenia, defined as T-score between −1.0 and −2.5 and osteoporosis defined as T-score < −2.5, T-scores were analyzed in postmenopausal women (n = 8) and men 50 years and older (n = 7). Of these 15 individuals, average T-score was −2.2 ± 1.3 (range −5.4 to 0.3), and 86.7% (n = 13) had abnormal results (osteopenia and osteoporosis), 53.3% (n = 8) had osteoporosis and 33.3% (n = 5) had osteoporosis.
We found a significant difference in Z-scores between male (−1.98 ± 1.33) and female patients (−.45 ± 0.82) t (23) = 3.487 (p = < 0.001). We did not find any differences in z-scores between different ethnic backgrounds. There was a strong negative correlation between Z-scores and Lyso-GL3 levels [r (15) = −.72, p = .001] and a moderate positive correlation between Z-scores and body mass index (BMI) [r (23) = .43, p = .033]. No correlation was found between Z-scores and calcium levels.
There is a strong negative correlation between T-scores and Lyso-GL3 levels [r (8) =: .86, p = .001] and a negative correlation between T-scores and participants’ ages at the time of DXA [r (13) = −.57, p = 0.028]. There is a positive correlation between T: scores and calcium levels [r (12) = .58, p = 0.030]. No significant correlation was observed between T-scores and BMI. There was no correlation between Z or T: scores and disease duration, duration of ERT use, renal function (measured by eGFR), GL3, creatinine, alkaline phosphatase levels, or their use of vitamin D or concomitant antiepileptic medications.
Conclusion
The findings of this cohort highlight the high prevalence of low bone mineral density in FD and correlations of low Z and T: scores with elevated levels of Lyso-GL3, and low calcium levels. We did not find correlations with renal function, and vitamin D levels. We discuss etiology, prevention, and treatment strategies for osteopenia/osteoporosis in Fabry disease.
Supplementary Information
The online version contains supplementary material available at 10.1186/s13023-025-03601-x.
Publication and source details
Original title: Assessing osteopenia and osteoporosis with dual-energy x-ray absorptiometry studies in Fabry disease
Alyaa Shmara; Grace Lee; Mania Mgdsyan; Kathy Hall; Nadia Sadri; Angela Martin-Rios; Kelsey Valentine; Tatiana Kain; Madeleine Pahl; Lynda E. Polgreen; Virginia Kimonis
Orphanet Journal of Rare Diseases · 2025
© The Author(s) 20252025https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.http://dx.doi.org/10.13039/100004339SanofiRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T02:05:31.375106+00:00
DOI: 10.1186/s13023-025-03601-x · PMC12042328